Apotex is proud to be delivering important savings to the Canadian Healthcare System, and to patients with Multiple Myeloma and Myelodysplastic Syndrome, with our MADE IN CANADA lenalidomide product.
The purpose of this study is to gain a better understanding of the febrile neutropenia treatment protocols used across Canada for adult patients receiving chemotherapy for solid organ cancers.
CAPhO members are invited to attend the Charting New Directions in the Treatment and Management of Chronic Lymphocytic Leukemia session hosted by AstraZeneca.
CAPhO member Maria Marchese received a 2020 research grant for her project, Perceptions and Experiences of Cancer Patients Accessing a Pharmacist-led Medical Cannabis Consultation Service in Toronto, Canada. Read more about the project in this latest post.
It is amazing to think that CAPhO is already 25 years old! It seems like just yesterday, this was a dream of Larry Broadfield's and now look at the thriving organization CAPhO has become!
